← Back to ASND

Ascendis Pharma A/S - Ordinary Share financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in EUR millions; per-share values use EUR.

Filed statements

EUR; millions except EPSSep 2025Filed 12/11/2025Jun 2025Filed 07/08/2025Mar 2025Filed 01/05/2025Sep 2024Filed 12/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 01/05/2025Sep 2023Filed 14/11/2024Jun 2023Filed 03/09/2024
€214€158€101€58€36€96€48€47
−€61−€39−€95−€99−€109−€131−€162−€121
−€1.00−€0.64−€1.58−€1.72−€1.91−€2.30−€2.88−€2.16

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.